Sci Pharm 85(1):4 [DOI] [PMC free article] [PubMed] [Google Scholar] Kandemir MF, Kkler S, alayan C, Gr C, Batl AA, Gulcin I (2017b) Therapeutic effects of silymarin and naringin on methotrexate-induced nephrotoxicity in rats: biochemical evaluation of anti-inflammatory, anti-apoptotic and anti-autophagic properties
Deletion of the four phospholipid hydroperoxide glutathione peroxidase genes accelerates aging in Caenorhabditis elegans
Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, Finch CE, et al
KurowskiMSeysSBoniniMDel GiaccoSDelgadoLDiamantZet alPhysical exercise, immune response, and susceptibility to infections-current knowledge and growing research areas
The investment reflects the company's strategic commitment to scaling operations in response to increasing therapeutic uptake In April 2024, Eli Lilly and Company launched Zepbound (tirzepatide) in several European markets following regulatory approval for obesity management
Additionally, other factors, such as hyperleptinemia, tissue dysfunction, compromised antioxidant defense, chronic inflammation, and postprandial ROS generation, also contribute to oxidative stress in individuals with obesity [53]